Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Horizons Psychedelic Stock Index ETF (PSYK.NE)

Horizons Psychedelic Stock Index ETF (PSYK.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund Globe NewsWire - Tue Sep 21, 2021

TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce...

PSYK.NE : 6.5500 (-0.30%)
PSYK : 16.48 (+0.30%)
PHRRF : 0.1800 (+7.78%)
PHRM.CN : 0.2450 (+4.26%)
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose Globe NewsWire - Tue Sep 7, 2021

VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...

PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1200 (+4.35%)
AGNPF : 0.0872 (-2.02%)
Optimi Health Appoints New Chief Executive Officer Globe NewsWire - Tue Aug 31, 2021

VANCOUVER, British Columbia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“ Optimi ” or the “ Company ”), developers of a vertically integrated...

PSYK.NE : 6.5500 (-0.30%)
OPTI.CN : 0.3500 (+9.38%)
OPTHF : 0.2437 (-0.93%)
Algernon Pharmaceuticals Announces Small Cell Lung Cancer Ifenprodil Research Program and Appoints Dr. William North as Lead Consultant Globe NewsWire - Wed Aug 11, 2021

VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical...

PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1200 (+4.35%)
AGNPF : 0.0872 (-2.02%)
Optimi Health Updates Launch of Online Functional Mushroom Sales Globe NewsWire - Tue Aug 10, 2021

VANCOUVER, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...

PSYK.NE : 6.5500 (-0.30%)
OPTI.CN : 0.3500 (+9.38%)
OPTHF : 0.2437 (-0.93%)
Algernon Pharmaceuticals Announces Exclusive Licensing Agreement with Dartmouth College Globe NewsWire - Mon Aug 9, 2021

VANCOUVER, British Columbia, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical...

PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1200 (+4.35%)
AGNPF : 0.0872 (-2.02%)
Optimi Health Strengthens Clinical and Regulatory Expertise Globe NewsWire - Tue Jul 27, 2021

VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), as part of its strategic aim to fully investigate...

PSYK.NE : 6.5500 (-0.30%)
OPTI.CN : 0.3500 (+9.38%)
OPTHF : 0.2437 (-0.93%)
Algernon Pharmaceuticals Announces 70% Enrollment of its Ifenprodil IPF and Chronic Cough Phase 2 Human Study Globe NewsWire - Wed Jul 7, 2021

VANCOUVER, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: AGNPF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical...

PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1200 (+4.35%)
AGNPF : 0.0872 (-2.02%)
Algernon Pharmaceuticals Announces it Will Not Advance Ifenprodil into Phase 3 Trial for COVID-19 Globe NewsWire - Tue Jul 6, 2021

VANCOUVER, British Columbia, July 06, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...

PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1200 (+4.35%)
AGNPF : 0.0872 (-2.02%)
Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021 Globe NewsWire - Thu Jun 17, 2021

VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to announce that...

PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1200 (+4.35%)
AGNPF : 0.0872 (-2.02%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas Barchart - Thu Apr 25, 6:30PM CDT
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot